Key Points
- CEO Yogesh Jashnani bought 31,000 shares at $0.78 each for $24,180, increasing his direct ownership by 4.46% to 726,475 shares.
- AirSculpt’s latest reported quarter fell short of expectations: EPS was $0.01 versus $0.02 expected, while revenue of $42.9 million missed the $44.14 million forecast.
- Analyst sentiment is mixed, with a consensus “Hold” rating and a $2.75 target price; the stock opened at $0.72 and has traded between $0.52 and $6.13 over the past year.
AirSculpt Technologies, Inc. (NASDAQ:AIRS - Get Free Report) CEO Yogesh Jashnani acquired 31,000 shares of the business's stock in a transaction on Wednesday, November 11th. The stock was purchased at an average price of $0.78 per share, for a total transaction of $24,180.00. Following the acquisition, the chief executive officer directly owned 726,475 shares in the company, valued at $566,650.50. This represents a 4.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
AirSculpt Technologies Stock Performance
NASDAQ:AIRS opened at $0.72 on Friday. The firm has a 50-day moving average of $1.73 and a two-hundred day moving average of $3.04. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.85 and a quick ratio of 0.79. The stock has a market cap of $53.24 million, a P/E ratio of -5.54 and a beta of 2.29. AirSculpt Technologies, Inc. has a 1-year low of $0.52 and a 1-year high of $6.13.
AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last announced its earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.01). AirSculpt Technologies had a negative return on equity of 9.43% and a negative net margin of 6.36%. The business had revenue of $42.90 million for the quarter, compared to analysts' expectations of $44.14 million.
Analysts Set New Price Targets
AIRS has been the subject of a number of analyst reports. Wall Street Zen downgraded AirSculpt Technologies from a "buy" rating to a "hold" rating in a report on Saturday, August 15th. Weiss Ratings restated a "sell (d-)" rating on shares of AirSculpt Technologies in a report on Monday, September 28th. Finally, Lake Street Capital cut their target price on AirSculpt Technologies from $3.00 to $1.00 and set a "buy" rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $2.75.
Check Out Our Latest Stock Analysis on AirSculpt Technologies
Institutional Trading of AirSculpt Technologies
Hedge funds and other institutional investors have recently bought and sold shares of the company. Vesey Street Capital Partners L.L.C. acquired a new stake in AirSculpt Technologies during the second quarter valued at approximately $136,458,810. BlackRock Inc. acquired a new position in shares of AirSculpt Technologies in the 2nd quarter worth approximately $5,755,000. Flputnam Investment Management Co. acquired a new position in shares of AirSculpt Technologies in the 2nd quarter worth approximately $3,114,000. GSA Capital Partners LLP bought a new stake in shares of AirSculpt Technologies in the 2nd quarter valued at approximately $1,913,000. Finally, Citizens Financial Group Inc. RI bought a new position in AirSculpt Technologies during the second quarter worth $1,321,000. 91.54% of the stock is owned by institutional investors.
About AirSculpt Technologies
(
Get Free Report)
AirSculpt Technologies, Inc. provides elective body-contouring and aesthetic procedures through its Elite Body Sculpture centers. Its services include fat removal and fat transfer, using its branded AirSculpt technique, which is designed to remove fat through small entry points without traditional liposuction incisions. The company's offerings also include procedures that use a patient's own fat to enhance or reshape areas of the body. AirSculpt Technologies serves patients through centers in the United States and Canada.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
